Rapid onset of control with budesonide Turbuhaler in patients with mild- to-moderate asthma

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 5, 1999, Pages 463-471

  Kemp, James ^a   Wanderer, Alan A ^a   Ramsdell, Joe ^b   Southern, D Loren ^c   Weiss, Steven ^d   Aaronson, Don ^a   Grossman, Jay ^e  

^a Bldg 2 ^*  (United States)

^b University Clinical Trials Inc   (United States)

^c Princeton Allerg and Asthma Assoc   (United States)

^d Mease Clinic   (United States)

^e Advanced Allergy and Asthma   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CROMOGLYCATE DISODIUM; IPRATROPIUM BROMIDE; NEDOCROMIL SODIUM; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL NEBULIZER; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UPPER RESPIRATORY TRACT INFECTION;

EID: 0033051452     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62722-6     Document Type: Article

References (36)

1. Laitinen LA, Heino M, Laitinen A, et al. Damage to the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 131:599-606.
2. Djukanovic R, Roche UR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142: 434-457.
3. 2ragonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-392.
4. Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non-steroid-dependent asthmatics. Am Rev Respir Dis 1990;142:832-836.
5. Lorentzson S, Boe J, Eriksson G, Persson G. Use of inhaled corticosteroids in patients with mild asthma. Thorax 1990;45:733-735.
6. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, Publication No. 97-4051, Bethesda, MD, 1997.
7. 2ragonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
8. Selroos O, Pietinalho A, Löfroos A-B, Riska H. Effect of early vs. late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-1234.
9. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.
10. Haahtela T, Järvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331: 700-705.
11. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992;44:375-407.
12. Thorsson L, Edsbäcker S, Conradson T-B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler pMDI. Eur Respir J 1994;7: 1838-1844.
13. Morris JF, Koski A, Temple WP, et al. Fifteen-year interval spirometric evaluation of Oregon predicted equations. Chest 1988;92:123-127.
14. Van den Berg JHM, Mol CR, Deelder RS, Thijssen JH. A quantitative assay of cortisol in human plasma by high performance liquid chromatography using a selective bonded stationary phase. Clin Chem Acta 1977;78(2): 165-172.
15. Ott L. An introduction to statistical methods and data analysis. Duxbury Press 1977;610-623.
16. Landis RJ, Heyman ER, Koch GG. Average partial association in three-way contingency tables: a review and discussion of alternative tests. Internat Stat Rev 1978;46:237-254.
17. Lee ET. Statistical methods for survival data analysis. Lifetime Learning Publications. 1980;129.
18. Bousquet J, Knani J, Henry C, et al. Under-treatment in a non-selected population of adult patients with asthma. J Allergy Clin Immunol 1996; 98:514-521.
19. 2 agonist inhalers and under-treatment of asthma. Br Med J 1993;306:1514-1518.
20. O'Byrne P, Cuddy L, Taylor DW, et al. Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care practice. Can Respir J 1996;3: 169-175.
21. Geddes D. Inhaled corticosteroids: benefits and risks. Thorax 1992;47: 404-407.
22. Barnes PJ. Inhaled glucocorticosteroids for asthma. N Engl J Med 1995; 332:868-875.
23. Barnes PJ. A new approach to the treatment of asthma. N Engl J Med 1989;321:1517-1527.
24. Ellull-Micallef R, Hansson E, Johansson SÅ. Budesonide: a new corticosteroid in bronchial asthma. Eur J Respir Dis 1980;61:167-173.
25. Engel T, Dirksen A, Heinig JH, et al. Single-dose inhaled budesonide in subjects with chronic asthma. Allergy 1991;46:547-553.
26. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 1991;143:1317-1321.
27. Kidney JC, Cockcroft DW, Boulet L-P, et al. The allergen-induced late asthmatic response as a model to test relative potency of inhaled corticosteroids. J Allergy Clin Immunol 1995; 95:(Part 2 of 2) 310.
28. Paggiario PL, Dente FL, Morelli MC, et al. Post allergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Am J Respir Crit Care Med 1994;149:1447-1451.
29. Gaddie J, Petrie GR, Reid IW, et al. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet 1973;2:280-281.
30. Boe J, Rosenhall L, Alton M, et al. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy 1989;44: 349-355.
31. Laursen LC, Taudorf E, Weeke B. High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. Eur J Respir Dis 1986;68: 19-28.
32. Toogood JH, Lefcoe NM, Haines DSM, et al. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 1977; 49:298-308.
33. Pedersen S, Hansen R. Budesonide treatment of moderate and severe asthma in children: a dose response study. J Allergy Clin Immunol 1995; 95:29-33.
34. Kraan J, Koeter GH, van der Mark THW, et al. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with anti-asthmatic drugs in patients with allergic asthma: a comparison between ASTRA and terbutaline. J Allergy Clin Immunol 1985;76: 628-636.
35. Jones AH, Langdon CG, Lee PS, et al. Pulmicort® Turbuhaler® once daily as initial prophylactic therapy for asthma. Respir Med 1994;88:293-299.
36. Venables TL, Addlestone MB, Smithers AJ, et al. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbuhaler and twice daily fluticasone propionate via dischaler at an equal daily dose of 400 μg in adult asthmatics. Br J Clin Res 1996;7:15-32.